Nagilactone E increases PD-L1 expression through activation of c-Jun in lung cancer cells-Reference-Cited by-同舟云学术

Nagilactone E increases PD-L1 expression through activation of c-Jun in lung cancer cells

Published:2020-07 Issue:7 Volume:18 Page:517-525
ISSN:1875-5364
Container-title:Chinese Journal of Natural Medicines
language:en
Short-container-title:Chinese Journal of Natural Medicines

Author:

CHEN Yu-Chi,HUANG Mu-Yang,ZHANG Le-Le,FENG Zhe-Ling,JIANG Xiao-Ming,YUAN Luo-Wei,HUANG Run-Yue,LIU Bo,YU Hua,WANG Yi-Tao,CHEN Xiu-Ping,LIN Li-Gen,LU Jin-Jian

Funder

Science and Technology Development Fund, Macau SAR

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,General Medicine

Reference36 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Immunosuppressive networks in the tumour environment and their therapeutic relevance;Zou;Nat Rev Cancer,2005

3. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012

4. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N Engl J Med,2015

5. Pembrolizumab for the treatment of non-small-cell lung cancer;Garon;N Engl J Med,2015

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Mini-Review on the Structural Characteristics and Anticancer Activity of Nagilactones;Current Traditional Medicine;2024-10

2. Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer;Phytomedicine;2024-06

3. From immune checkpoints to therapies: understanding immune checkpoint regulation and the influence of natural products and traditional medicine on immune checkpoint and immunotherapy in lung cancer;Frontiers in Immunology;2024-02-15

4. A comprehensive review on the medicinal usage of Podocarpus species: Phytochemistry and pharmacology;Journal of Ethnopharmacology;2023-06

5. DDR1 functions as an immune negative factor in colorectal cancer by regulating tumor‐infiltrating T cells through IL ‐18;Cancer Science;2022-08-24